In a 26-0 vote, the Senate Finance Committee Nov. 8 reported the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, bipartisan legislation that includes AHA-supported provisions to improve access to behavioral health care and delay Medicaid disproportionate share hospital reductions.

The AHA-supported provisions would provide Medicare incentives to integrate behavioral health and primary care; delay certain Medicaid disproportionate share hospital payment reductions for two years; and permanently grant state Medicaid programs the option to receive federal matching payments for substance use disorder treatment provided in certain institutions for mental diseases. The legislation also would ensure timely communication regarding telehealth and interstate licensure requirements, and extend certain Medicare payment provisions for physicians and clinical laboratory services.

Related News Articles

Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…
Headline
The Senate Appropriations Committee July 31 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services,…
Headline
The AHA released a new toolkit to improve continuity of care for patients with opioid and stimulant use disorders. Developed with support from the Centers for…
Headline
The Substance Abuse and Mental Health Services Administration July 28 released its latest national survey on drug use and mental health. Among the findings,…
Chairperson's File
Public
The recently enacted One Big Beautiful Bill Act will bring big changes to health care. AHA President and CEO Rick Pollack joined me for a Leadership Dialogue…
Headline
An analysis published July 14 by KFF found that use of the 988 Suicide and Crisis Lifeline has steadily increased since its launch in July 2022. To date, the…